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RESEARCH ARTICLE
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Locomotor Function, following Spinal Cord
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Abstract
Selenium is an essential element required for activity of several antioxidant enzymes,
including glutathione peroxidase. Because of the critical role of the antioxidant system in
responding to traumatic events, we hypothesized that dietary selenium supplementation
would enhance neuroprotection in a rodent model of spinal cord injury. Rats were main-
tained on either a control or selenium-enriched diet prior to, and following, injury. Dietary
selenium supplementation, provided as selenized yeast added to normal rat chow, resulted
in a doubling of selenium levels in the spinal cord. Dietary selenium reduced the time
required for recovery of bladder function following thoracic spinal cord injury. However, this
was not accompanied by improvement in locomotor function or tissue sparing.
Introduction
Spinal cord injury (SCI) is a prevalent clinical problem, with approximately 273,000 patients
living with SCI in the United States[1]. Young adults represent a particularly vulnerable popu-
lation due to their active lifestyle and higher prevalence of military service. A prophylactic sup-
plement to protect in the event of acute neurotrauma may be particularly beneficial to this high
risk group.
We investigated selenium supplementation as a prophylactic treatment for reducing dam-
age and improving functional outcomes following spinal cord injury. Selenium is essential for
the formation of selenoproteins, particularly in the CNS. However, different forms of selenium
are associated with varying toxicity levels[2]. Organic selenium supplements have much lower
levels of toxicity and fewer of the pathogenic effects that are commonly associated with high
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levels of inorganic selenium[3–6]. Selenomethionine can be incorporated in place of methio-
nine in tissues, allowing for storage of selenium in the event of a dietary deficiency.
The diets utilized in this study were formulated with selenized yeast, Sel-Plex1, to provide an
organic form of selenium supplementation. The selenium is present in the form of two amino
acids, selenomethionine and selenocysteine, as well as a variety of other seleno-compounds[7].
Selenized yeast has significantly lower toxicity than sodium selenite[8]. High levels of inorganic
selenium in the form of selenite can have detrimental neurological effects [9], however these
results have not been demonstrated with selenized yeast. In contrast, several studies have shown
beneficial effects of selenium in the progression of neurodegenerative diseases [10–12].
The brain and spinal cord prioritize the retention of selenium when dietary levels are deficient
[13], utilizing the selenium transporter, selenoprotein P (SelP), to supply physiological selenium
to the CNS[14, 15]. Selenoproteins are well characterized for their role in redox regulation[16–
18] and anti-inflammatory pathways[10, 19], both of which are implicated in the secondary
injury cascade following SCI [20–23]. In particular, several antioxidant enzymes, including gluta-
thione peroxidases and thioredoxin reductases, are selenoproteins, which require selenocysteine
for protein production. Reactive oxygen species initiate lipid hydrolysis, breakdown of cellular
membranes, mitochondrial dysfunction, and thus perpetuate the damaging secondary injury cas-
cade [24]. Increasing levels of selenium available in tissues prior to injury may prepare the CNS
to quickly synthesize selenoproteins to mitigate this series of damaging events.
The objective of this study was to examine the effect of supplementation with selenized
yeast on functional and pathological endpoints following SCI. Dietary selenium supplementa-
tion increased selenium tissue storage in the CNS, with no aberrant weight gain or other
adverse physiological changes between treatment groups. This increase in selenium levels did
not translate to a visible improvement in locomotion or lesion volume in the injured tissue, but
resulted in more rapid recovery of autonomous bladder expression.
Materials and Methods
Animal care and diet
Female Sprague-Dawley rats were obtained from Harlan at weaning and placed immediately
on either a control diet or on a selenium enriched diet (Se-yeast, Sel-Plex, Alltech, Nicholas-
ville, KY). The selenium enriched diet also used a standard rat chow as the diet base and incor-
porated a selenized yeast preparation (1.3ppm total selenium, approximately 19.5μg per day)
in which the yeast is grown in the presence of selenium. The control diet of normal rat chow
contained standard dietary levels of selenium (0.3ppm selenium, approximately 4.5μg per day)
and a yeast additive to account for the presence of selenized yeast in the selenium enriched
diet. The LD50 of acute administration of Sel-Plex is2500mg/kg in rats and the overall no
observed adverse effect level (NOAEL) is 30mg/kg/day whereas similar levels of inorganic
sodium selenite resulted in mortality and clinical pathologies. Animals were fed their respective
diets (n = 20 per diet) ad libitum for 16 weeks. In a separate study, animals received the diets
for 4 weeks, 8 weeks or 16 weeks followed by evaluation of Se levels in the spinal cord.
Throughout the trials, animals were weighed weekly, and immediately prior to receiving the
injury, to monitor health statuses of the rats as well as to check for any significant differences
in body weight of the animals at the time of injury. All animal procedures were approved by
the University of Kentucky Institute of Animal Care and Use Committee (IACUC).
Spinal cord injury and post-surgical care
Following 4 months of dietary supplementation, rats were subjected to a moderate contusive
SCI (150kdyn). Contusive SCI surgeries were performed as previously described[25]. In brief,
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rats were anesthetized with an intraperitoneal injection of ketamine (80mg/kg) and xylazine
(10mg/kg). The spinal cord was exposed via a T10 laminectomy. The rats received a moderate
(150kdyn) contusive thoracic SCI using the Infinite Horizons SCI injury device (Precision Sys-
tems and Instrumentation). Sham animals were handled identically, including the laminect-
omy procedure, but did not receive the thoracic SCI. Following SCI (n = 12) or sham surgery
(n = 8), the musculature and skin were closed with sutures and wound clips, respectively. As
part of routine post-surgical care, bladders were manually expressed twice daily using the
Credé maneuver[26] until the animal recovered autonomous bladder control. Bladder function
following injury was recorded as either non-functional (full bladder) or functional (empty to
half-full bladder) prior to manual voiding [27]. The number of days until each animal exhibited
autonomous bladder functional recovery was recorded. The rats also received injections of
Buprenorphine (0.05 mg/kg) twice daily to manage pain and Baytril (5-10mg/kg) twice daily
for three days post injury to prevent development of post-surgical infection. Animals were
maintained on their respective diets until the time of euthanasia.
Spinal cord and cortical selenium levels
A separate cohort of animals was also maintained on the two different diets for 1 to 4 months
under the conditions as described above. For the SCI studies, animals were fed ad libitum for 4
months (n = 5 per dietary group). Immediately following the feeding regimen animals received
the moderate contusive spinal cord injury described above. 24 hours post injury, fresh tissue
from spinal cord sections both rostral and caudal to the injury site and cortical samples were
removed and flash frozen in liquid nitrogen. Selenium levels were then analyzed by liquid chro-
matography-mass spectroscopy (LC-MS). Values rostral and caudal to the injury site were
averaged for each animal. One value was removed from spinal cord dataset due to being an
extreme outlier (greater than 3 standard deviations from the mean).
Behavioral assessment
At three days following SCI, two investigators blinded to treatment groups assessed open field
locomotor functional recovery using the Basso, Beattie, and Bresnahan (BBB) locomotor rating
scale[28]. Locomotor testing was then repeated once weekly for 6 weeks following injury. At 3
days following injury there is a substantial injury effect. With a moderate injury animals lose
motor control of their hind limbs. Over 6 weeks, rats typically demonstrate a gradual improve-
ment in locomotion that typically plateaus around a BBB score of 13, indicating that animals
have frequent to consistent weight support in plantar stepping and frequent coordination.
When discrepancy occurred between observers, the lower score was assigned to the animal’s
performance.
Tissue histology
Following the final behavioral testing, animals were given an intraperitoneal injection of a fatal
overdose of sodium pentobarbital and then perfused with ice-cold phosphate buffered saline
(PBS), followed by fixation with a 4% paraformaldehyde/PBS solution. Spinal cord tissues were
kept at 4°C in a 4% paraformaldehyde solution for 4 hours and then transferred to a 30%
sucrose solution overnight at 4°C for cryopreservation. The fixed tissues were transferred into
OCTmedium for cryosectioning at -25°C. Tissue histology was evaluated in a subset of animals
randomly selected from each group (n = 8 for each injury group, n = 5–7 for sham injured
groups). Transverse spinal cord sections (20μm thick) were collected every 100μm and
mounted onto microscope slides (Fisher Superfrost). Sections were stained utilizing erio-
chrome cyanine RC and cresyl violet [29, 30]. Areas of spared and lesioned tissue were
Selenium and Spinal Cord Injury
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measured for sections extending 0.7mm on either side of the injury epicenter using Scion Imag-
ing analysis software (Scion Corporation, Frederick, MD). Utilizing the Cavalieri method[31],
the total volume of tissue in the lesion or in spared tissue was calculated. The investigator was
blinded to treatment groups until all parameters had been measured and calculated.
Statistical Analysis
Data represented in each figure are shown as mean±standard deviation. Using GraphPad
Prism 6.0, differences in weekly weight gain were evaluated by repeated measures, one-way
ANOVA encompassing the 16 week feeding period. Additionally, Student’s t-test (significance
at p<0.05) was used to compare final weights, and also time to autonomous bladder function
in the SCI groups. Differences in behavioral assessment (BBB Scores) between treatment
groups were assessed by mixed factorial ANOVA with significance assigned at p<0.05 [32]. As
the two sham groups had the same response on each of the days, the ANOVA was conducted
on the SCI+SelPlex and SCI-control diet groups. Tissue selenium content was compared using
Student’s t-test (p<0.05) between control and selenium-enriched diets. A two-way ANOVA
evaluating the six week scores of locomotor function and time to recovery of autonomous blad-
der function was also performed.
Results
Animal weights
To ascertain the effect of the selenium-enriched and control diets on body weight throughout
the course of the study, animals were weighed weekly as described above (n = 25 for each diet).
Weight gain showed no significant differences between rats maintained on the control (+yeast)
rat chow and the yeast-selenium enriched diet (Fig 1).
Selenium levels
Data from liquid chromatography mass spectroscopy (LC-MS) showed that dietary enrich-
ment with selenium increased tissue storage of selenium. In the spinal cord, cortex, and liver,
Fig 1. Dietary selenium enrichment does not affect overall weight gain. Rats were weighed weekly. No
differences in body weight were seen between selenium enriched rats and rats maintained on control diet
(n = 25).
doi:10.1371/journal.pone.0147716.g001
Selenium and Spinal Cord Injury
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selenium levels increased by approximately 2-fold between the control diet and selenium
enriched diet (Fig 2). The magnitude of increased tissue storage was similar for animals on the
selenium enriched diet for one, two and four months.
Bladder function
Animals (n = 12 per diet) maintained on selenium enriched diets regained bladder function by
3±0.4 days after injury as compared to rats on a control diet, at 5±0.5 days (p<0.05) (Fig 3).
Animals that received sham surgeries did not lose autonomous bladder control.
Locomotor functional recovery
Injured animals in both groups had a complete loss of hindlimb locomotor function immedi-
ately following surgery, confirming that the contusion injury was effective. Three days after
injury, all rats exhibited slight motor recovery, as evident from the BBB scores, which reflect
slight movement of two joints and extensive movement of the third joint. Over the course of
the 6 week behavioral testing, all injured animals showed a steady improvement in locomotor
function, plateauing around the second week with overall function that included consistent
stepping, occasional to frequent coordination, and occasional correct paw placement. In the
injured animals, there was no significant difference in locomotor functional recovery, over
time or during the final behavioral testing, between those fed the control diet and animals fed
the selenium-enriched diet (Fig 4). Sham animals in both dietary groups showed no loss of
locomotor function following sham surgery. We also compared the six week BBB scores with
time to recovery of bladder function using a two-way ANOVA. The results were significant
(p<0.05) for interaction, diet, and functional marker.
Tissue lesion volume
Staining for myelin and neuronal cell bodies showed no significant difference between the two
injured groups in total lesion volume, or in the total amount of gray matter and white matter
sparing after injury (Fig 5). Sham injured animals showed no tissue lesion.
Discussion
The CNS maintains a high priority for selenium storage in deficient conditions, suggesting a
critical role of selenium in CNS tissues [13, 33–35]. Dietary selenium supplementation has
been examined previously for metastatic brain tumors[36], Alzheimer’s Disease[37], ischemia
[38], and Parkinson’s Disease[39] and TBI [40]. One previous study examined the effects of
selenium on SCI [41], although the experimental conditions differed markedly. Yeo and col-
leagues injected sodium selenite (10-50ng/kg) mixed with matrigel directly into the lesion site
immediately following a dorsal hemisection injury. This study observed a reduction in apopto-
tic cell death, decreased glial fibrillary acidic protein (GFAP) positive cells, and a dramatic
improvement in locomotor function in selenium treated rats. Selenium supplementation has
also been recently evaluated in a model of ischemic/reperfusion injury to the rat spinal cord fol-
lowing blockage of the abdominal aorta [42]. The rats received feed containing 5 mg/L sele-
nium for two weeks prior to experimentation, tissue levels were not evaluated. Rats were
euthanized 7 days following a 30 minute blockade of the abdominal aorta. Selenium supple-
mentation increased cell survival, decreased necrosis and edema, an increased expression of cil-
iary neurotrophic factor (CNTF) and it’s receptor α (CNTF-Rα) [42].
Pre-injury dietary supplementation in this study resulted in increased CNS tissue levels of
selenium, providing increased bioavailability of seleno-amino acids for the production of
Selenium and Spinal Cord Injury
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Fig 2. Dietary selenium enrichment increases selenium tissue storage.CNS and liver selenium levels
were analyzed by LC-MS. The results indicate that supplemented selenium crosses the blood-brain barrier
and is available for incorporation into spinal cord and cortical tissue. Values are mean±SD, n = 5/group.
doi:10.1371/journal.pone.0147716.g002
Selenium and Spinal Cord Injury
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selenoproteins. However, the increased selenium levels did not result in improved tissue spar-
ing. In behavioral tasks, the rats receiving a selenium-enriched diet did not exhibit significant
improved locomotor function post-injury as compared to animals whose diet consisted of nor-
mal rat chow.
Rats in the selenium enriched diet group were able to regain autonomous control of bladder
expression following spinal cord contusion injury more quickly than rats maintained on the
control diet. Initiation of autonomous micturition has been examined as a marker for recovery
of sensory-motor function in previous spinal cord contusion studies [43, 44].
Neurological control of bladder function is controlled through splanchnic parasympathetic
nerves (located in the sacral spinal cord S2-S4), pudendal nerves (also in the sacral spinal cord
Fig 3. Dietary selenium supplementation improves the time to recovery of bladder function.Rats
receiving selenium supplementation recovered bladder function in an average of 3 days±0.4 as compared to
rats on a control diet, which recovered bladder function in 5 days±0.5. Recovery of bladder expression is an
additional functional marker for improvement. Values are mean±SD, p<0.05.
doi:10.1371/journal.pone.0147716.g003
Fig 4. Dietary selenium supplementation does not improve locomotor functional recovery. Recovery
was evaluated weekly after injury using the BBB scale. No difference in improvement was seen between the
two diets in the injured rats. Sham animals showed no change in performance after laminectomy. Values are
mean±SD (n = 12 injured, n = 8 sham).
doi:10.1371/journal.pone.0147716.g004
Selenium and Spinal Cord Injury
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S2-S4), and thoracic sympathetic nerves (cell bodies originating at T10-L2 spinal cord levels).
Sympathetic innervation of the bladder plays a crucial role in closing the internal urethral
sphincter and of blood vessels in the detrusor muscle of the bladder. Although histological
examination did not show an overall improvement in total lesion volume, it is possible that
sympathetic neurons present at the site of injury (thoracic level T10) were protected with sele-
nium treatment.
Fig 5. Dietary selenium supplementation does not reduce lesion volume following SCI. Spinal cords
sections (20μm) were stained for cell bodies and myelin. Total lesion volume (A) and total tissue sparing (B)
revealed a significant injury effect (p<0.01) between sham and injured. No significant difference in lesion
volume or tissue sparing was seen between the control injured and the selenium injured group. Additionally,
there were no significant differences in grey matter sparing and white matter sparing (n = 12 injured).
doi:10.1371/journal.pone.0147716.g005
Selenium and Spinal Cord Injury
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Although histological examination did not show an overall improvement in total lesion vol-
ume, it is possible that sympathetic neurons present at the site of injury (thoracic level T10)
were protected with selenium treatment. Ferrero and colleagues noted that the closer a lesion
was to T10, the slower the bladder recovery time [45]. They also commented that because of
the involvement of this region in sympathetic and sensory innervation of the ureter and kidney,
lesions in this area should be avoided for SCI investigations of micturition pathways.
In rat contusion (incomplete injury) models of SCI, rats spontaneously recover voluntary
bladder control in the days to weeks following injury. Human patients with incomplete SCI do
not exhibit recovery of voluntary bladder control. Disruptions in bladder and bowel function
are very important clinical pathologies to SCI patients, however, disconnect between clinical
outcomes and those found in experimental models may limit the translation of bladder func-
tional recovery in preclinical models to patient application.
Overall, the results do not support our hypothesis that selenium supplementation would
result in improved outcomes following SCI. However, findings indicating bladder functional
recovery without associated improvement in locomotor behavioral tasks suggest that these
improvements in bladder function may be important markers for functional recovery[46, 47].
Current studies are examining effects of selenium-enriched and selenium-deficient diets on
levels of selenoproteins and related enzyme activities in both naïve and traumatic brain injured
animals. The antioxidant natures of many of the selenoproteins in the CNS, along with the
results from this study suggest, that while selenium’s effects may be modest in this SCI model,
examining various levels of selenium to attenuate neurodegenerative pathways warrants fur-
ther research.
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